Industry Insights
-
Getting Executive Backing For A Digital QMS
8/26/2021
This article offers guidance that will help you quantify and communicate the importance of quality, and how a digital QMS delivers considerable savings.
-
TMT Labeling For Optimized Sample Preparation In Quantitative Proteomics
5/13/2025
Leverage the power of Tandem Mass Tags (TMT) quantitative proteomics to gain deep insights into cellular dynamics, disease mechanisms, and drug targeting.
-
The Case For Early Use Of cGMP Raw Materials
7/14/2023
Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability.
-
Cell Culture Media Analysis For Gene Therapy
1/13/2022
Efficient viral vector production is a key element for gene therapy manufacturing where improving overall yield is still the biggest hurdle.
-
A Multi-Attribute Analysis CE Platform Assesses Identity And Titer Of LVVs
3/13/2023
As lentiviral vectors become more attractive options for CGT applications, sponsors need robust, efficient analytical platforms to accommodate upstream and downstream assessment.
-
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C
This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
Ready To Amplify Plasmid (pDNA) In Bacteria?
11/14/2023
Explore how to use and amplify pDNA from the development of recombinant proteins and viral vectors to advanced bio-therapeutics such as mRNA vaccines.
-
Innovations In Peptide Manufacturing
1/23/2025
The peptide manufacturing industry is evolving to meet the demands of efficiency, scalability, and sustainability. Learn how the latest innovations are addressing these challenges.
-
Partnering At Every Stage: Providing Capable Capacity For Manufacturing
Finding a CDMO partner with the requisite expertise, materials, external supply chain, and capacity is key to maximizing a therapy’s chances of commercial success.
-
Solid Tumors: The Next Frontier Of Cancer Immunotherapy
2/14/2024
With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.